Showing results (961-970 of 2,915) with videos related to
Sort By:
Pageof 292
Cancer Gene Therapy|March 25, 2022
HDAC11 activity contributes to MEK inhibitor escape in uveal melanomaSathya Neelature Sriramareddy, Fernanda Faião-Flores, Michael F Emmons, et al.Cancer Gene Therapy|March 30, 2022
Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signalingJohn J Park, Ashleigh Stewart, Mal Irvine, et al.Cancer Gene Therapy|March 8, 2022
Silencing of RND3/RHOE inhibits the growth of human hepatocellular carcinoma and is associated with reversible senescenceSara Basbous, Lisa Paysan, Sandra Sena, et al.Cancer Gene Therapy|March 4, 2000
Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growthI Campbell, T Moyana, S Carlsen, et al.Cancer Gene Therapy|March 4, 2000
In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirusT Ichikawa, T Tamiya, Y Adachi, et al.Cancer Gene Therapy|March 4, 2000
Effectiveness of cancer vaccine therapy using cells transduced with the interleukin-12 gene combined with systemic interleukin-18 administrationI Hara, H Nagai, H Miyake, et al.Cancer Gene Therapy|March 4, 2000
Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomesN Yerushalmi, U Brinkmann, E Brinkmann, et al.Cancer Gene Therapy|March 4, 2000
Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanismsC A Kruse, C Lamb, S Hogan, et al.Cancer Gene Therapy|March 4, 2000
Tetracycline-induced expression of an anti-c-Myb single-chain antibody and its inhibitory effect on proliferation of the human leukemia cell line K562K Kasono, Y Heike, J Xiang, et al.Cancer Gene Therapy|July 27, 1999
The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancerN P Rizk, M Y Chang, C El Kouri, et al.Pageof 292